Corey S. Goodman, Ph.D.

Corey Goodman is a scientist, educator and entrepreneur. He spent 25 years as professor of biology at Stanford University and Evan Rauch Chair of Neurobiology at U.C. Berkeley (Dept. of Molecular and Cell Biology), where he was a Howard Hughes Medical Institute investigator, head of the neurobiology division, and co-founder and director of the Wills Neuroscience Institute. He is currently adjunct professor of neuroscience in the Wills Neuroscience Institute at U.C. Berkeley. 

Corey is an elected member of the National Academy of Sciences, American Academy of Arts and Sciences, and American Philosophical Society, and recipient of many honors including the Alan T. Waterman Award, Canada Gairdner Biomedical Award, March-of-Dimes Prize, Reeve-Irvine Research Medal, Dawson Prize in Genetics, and Gruber Prize in Neuroscience. 

Corey co-founded eight biotechnology companies. The first was Exelixis, then he led the second, Renovis, as president and CEO from a private to public company until its acquisition by Evotec. At Pfizer, he was

president of the Biotherapeutics and Bioinnovation Center and a member of the executive leadership team.

Today, Corey is a managing partner of venBio Partners. In addition to FogPharma, he is chair of the board of ALX Oncology, Tollnine, Second Genome, Axonis, Attralus, MindRhythm and Axent. He is a member of the board of NFlection. He chaired Labrys Biologics until its acquisition by Teva, and was a founding investor/board member of Checkmate, which was acquired by Regeneron. The Labrys drug, called Ajovy, is a CGRP antibody for chronic migraine that was approved by the FDA in 2018. venBio, launched in 2011, has five FDA-approved drugs.

Amongst his many public policy roles, Corey is a member of the University of California Innovation Council, and former chair of both the California Council on Science and Technology (advising the California governor and state legislature) and the National Research Council’s (NAS) Board on Life Sciences (advising the federal government).

Corey holds a B.S. from Stanford University and a Ph.D. from U.C. Berkeley.  He was a Helen Hay Whitney postdoctoral fellow at U.C. San Diego.